Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.5K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.5K
Genomics02:02

Genomics

39.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivering transformational change for patients and the environment through England's National Cancer Plan.

The Lancet. Oncology·2026
Same author

From clinical genetics to genomic-based public health screening programmes: duty-based ethics as a guide for responsible implementation.

European journal of human genetics : EJHG·2026
Same author

UK Public Focus Groups on Healthcare's Environmental Impacts: A Critical Analysis of Co-Benefits Approaches.

Sociology of health & illness·2025
Same author

Can care ethics help healthcare systems address their environmental harms? Findings from focus groups with members of the UK public.

Social science & medicine (1982)·2025
Same author

Future advances in shoulder arthroplasty surgery.

Journal of clinical orthopaedics and trauma·2025
Same author

Focusing attention on physicians' climate-related duties may risk missing the bigger picture: towards a systems approach to health and climate.

Journal of medical ethics·2024

Related Experiment Video

Updated: Dec 27, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K

Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities.

Sarah Briggs1, Ingrid Slade2

  • 11Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN UK.

Current Genetic Medicine Reports
|March 3, 2020
PubMed
Summary

Population screening for cancer susceptibility genes offers clinical and cost benefits. Evaluating these programs requires adapting existing frameworks to account for genetic complexities and population values.

Keywords:
CancerCancer genomicsGenetic susceptibilityPopulation healthPublic healthScreening

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K

Related Experiment Videos

Last Updated: Dec 27, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K

Area of Science:

  • Genomic Medicine
  • Cancer Prevention
  • Public Health

Background:

  • Decreasing costs of genomic testing and increased understanding of cancer susceptibility genes.
  • Growing interest in integrating genetic testing and polygenic risk scores into population cancer screening.
  • Evidence suggests potential clinical and cost-effectiveness of such screening programs.

Purpose of the Study:

  • Explore frameworks for evaluating screening programs.
  • Assess the applicability of existing standards to population screening for cancer susceptibility.
  • Consider unique issues and outcomes relevant to genetic cancer screening.

Main Methods:

  • Review of existing screening program evaluation frameworks.
  • Analysis of the alignment between traditional genetic testing and population screening principles.
  • Consideration of prognostic shifts and familial health implications.

Main Results:

  • Tensions exist between traditional genetic testing (high specificity) and population screening (low specificity) principles.
  • Existing screening guidelines may not fully align with genetic test evaluation.
  • Population screening for cancer genetic risk shifts focus to prognostication with broader health implications.

Conclusions:

  • Existing screening frameworks need modification to evaluate genetic screening for cancer risk.
  • Incorporating complexities of outcomes and population values is crucial.
  • Further research, policy development, and public dialogue are essential for informed implementation.